Publications

September 2023 (Revised September 2023)
Teaching Note

Roche: Innovation and Access to Healthcare

By: George Serafeim

Teaching Note for HBS Case No. 123-075. In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to... View Details

Keywords: ESG; Access To Care; Healthcare; Healthcare Access; Innovation; Social Impact; Affordable; Health Care and Treatment; Innovation and Invention; Product Development; Resource Allocation; Corporate Social Responsibility and Impact; Health Industry

29 May 2020
Op-Ed

How Leaders Are Fighting Food Insecurity on Three Continents

vulnerable families and individuals are suffering from job losses, mental health issues, and food shortages due to significant disruptions in the food system.” SecondBite is a national food relief organization committed to “ending waste,... View Details

Keywords: by Howard Stevenson and Shirley Spence; Agriculture & Agribusiness

10 Oct 2000
Research & Ideas

Cross-Sector Collaboration: Lessons from the International Trachoma Initiative

The aim, write the authors, is "to deepen our understanding of the process of cross-sector collaboration in the public health arena and the factors contributing to effective partnering." They begin with brief descriptions of... View Details

Keywords: by Diana Barrett, James Austin & Sheila McCarthy

22 Sep 2003
Research & Ideas

How Businesses Can Respond to AIDS

Asia: Building Sustainable Partnerships," held September 4 and 5, brought together over seventy participants from business, government, non-governmental organizations, and activist groups to share experiences and offer a strong View Details

Keywords: by Martha Lagace

April 2006 (Revised May 2009)
Case

Inverness Medical Innovations - Born Global (A)

Ron Zwanziger has just started his third company, having just sold the last one for $1.3 billion to Johnson & Johnson. As part of the deal with J&J, certain assets were transferred to the new company, Inverness Medical Innovations, which, at the time of its creation,... View Details

Keywords: Globalized Firms and Management; Mergers and Acquisitions; Entrepreneurship; Health Care and Treatment; Corporate Finance; Health Industry; Health Industry; Waltham

25 Apr 2005
Research & Ideas

New Learning at American Home Products

division integrating product development and marketing, but without significant research capability. For all but chemicals and prescription drugs, the corporate focus was on marketing, especially advertising.24 In prescription drugs, the... View Details

Keywords: by Alfred D. Chandler Jr.; Health; Health; Health; Health

July 2000 (Revised September 2005)
Case

Guidant: Radiation Therapy

Describes a potential new approach to treating cardiac disease--radiation therapy. Guidant, a leading medical device maker, faces a choice about whether to pursue this new and risky technology and, if so with what strategy. View Details

Keywords: Entrepreneurship; Decisions; Innovation Strategy; Health Care and Treatment; Product Design; Corporate Strategy; Medical Specialties; Health Industry; Health Industry

April 2025
Supplement

#FutureFresenius: 'Committed to Life' in 2024 and Beyond (B)

By: David J. Collis, Benjamin C. Esty and Haisley Wert

From February 2024 onward, Fresenius SE & Co. KGaA continued to make progress on the #FutureFresenius transformation that CEO Michael Sen had initiated in October 2022. The company had completed the initial "reset" phase and moved into the "revitalize" portion of the... View Details

Keywords: Corporate Strategy; Finance; Transformation; Leading Change; Health Industry; United States; Germany

September 2006 (Revised April 2007)
Case

Medtronic Vision 2010

By: Lynda M. Applegate

Describes the company's year-long efforts to transition from a medical device company selling products to physicians for use with patients suffering chronic end-stage disease, to a medical technology company providing life-long solutions for people with chronic... View Details

Keywords: Business Plan; Transition; Decision Choices and Conditions; Corporate Entrepreneurship; Financial Management; Financing and Loans; Health Care and Treatment; Innovation and Invention; Strategic Planning; Health Industry

October 2024
Case

Allurion: Competing in the Age of GLP-1

By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso

Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details

Keywords: Corporate Entrepreneurship; Health Care and Treatment; Global Strategy; Competitive Strategy; Market Entry and Exit; Health Industry; Health Industry; United States; United Kingdom; France; India; Brazil; Middle East

October 2020
Case

Genomics in the Family Office

By: Lauren Cohen, Ronnie Stangler and Spencer C. N. Hagist

Alice Anane is the member of a large, wealthy family that collectively operates a multi-pronged family business in Israel. Upon discovering partway into her pregnancy that the rapidly degenerative brain disease her father succumbed to now threatens her and potentially... View Details

Keywords: Family Business; Health Disorders; Strategic Planning; Corporate Governance

October 2020 (Revised November 2023)
Case

COVID-19 Testing at Everlywell

By: Jeffrey J. Bussgang and Olivia Hull

In March 2020, as COVID-19 spreads rapidly across the U.S., Everlywell founder Julia Cheek considers how to respond as a small start-up specializing in at-home lab testing. After making dramatic budget cuts, she decides to pivot the organization to address the... View Details

January 2025
Supplement

Creating Value by Splitting Aster (B): Can One Minus One Equal Two?

By: V.G. Narayanan and Kairavi Dey

Keywords: Corporate Governance; Corporate Accountability; Leadership; Change Management; Mergers and Acquisitions; Health Industry; Asia; India; Middle East; United Arab Emirates

April 2004 (Revised May 2007)
Case

Conor Medsystems

By: Donald N. Sull, Robert F. Higgins, Linda A. Cyr and Bijan Salehizadeh

Conor Medsystems had developed a drug-eluting stent that could capture significant share of the $5 billion global market. Chief executive officer, Frank Litvack, is considering alternative sources of financing to test the device. View Details

Keywords: Entrepreneurship; Health Testing and Trials; Corporate Finance; Medical Devices and Supplies Industry